Literature DB >> 23055515

Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons.

Zoltán Péterfi1, Gabriella M Urbán, Orsolya I Papp, Beáta Németh, Hannah Monyer, Gábor Szabó, Ferenc Erdélyi, Ken Mackie, Tamás F Freund, Norbert Hájos, István Katona.   

Abstract

Although endocannabinoids have emerged as essential retrograde messengers in several forms of synaptic plasticity, it remains controversial whether they mediate long-term depression (LTD) of glutamatergic synapses onto excitatory and inhibitory neurons in the hippocampus. Here, we show that parvalbumin- and somatostatin/metabotropic glutamate receptor 1(a) (mGlu(1a))-positive GABAergic interneurons express diacylglycerol lipase-α (DGL-α), a synthesizing enzyme of the endocannabinoid 2-arachidonoylglycerol (2-AG), albeit at lower levels than principal cells. Moreover, this lipase accumulates postsynaptically around afferent excitatory synapses in all three cell types. To address the role of retrograde 2-AG signaling in LTD, we investigated two forms: (1) produced by postsynaptic spiking paired with subsequent presynaptic stimulation or (2) induced by group I mGlu activation by (S)-3,5-dihydroxyphenylglycine (DHPG). Neither form of LTD was evoked in the presence of the mGlu(5) antagonist MPEP [2-methyl-6-(phenylethynyl)-pyridine], the DGL inhibitor THL [N-formyl-l-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester], or the intracellularly applied Ca(2+) chelator BAPTA in CA1 pyramidal cells, fast-spiking interneurons (representing parvalbumin-containing cells) and interneurons projecting to stratum lacunosum-moleculare (representing somatostatin/mGlu(1a)-expressing interneurons). Both forms of LTD were completely absent in CB(1) cannabinoid receptor knock-out mice, whereas pharmacological blockade of CB(1) led to inconsistent results. Notably, in accordance with their lower DGL-α level, a higher stimulation frequency or higher DHPG concentration was required for LTD induction in interneurons compared with pyramidal cells. These findings demonstrate that hippocampal principal cells and interneurons produce endocannabinoids to mediate LTD in a qualitatively similar, but quantitatively different manner. The shifted induction threshold implies that endocannabinoid-LTD contributes to cortical information processing during distinct network activity patterns in a cell type-specific manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055515      PMCID: PMC3494839          DOI: 10.1523/JNEUROSCI.1676-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  83 in total

Review 1.  Long-term depression in the CNS.

Authors:  Graham L Collingridge; Stephane Peineau; John G Howland; Yu Tian Wang
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

Review 2.  Map plasticity in somatosensory cortex.

Authors:  Daniel E Feldman; Michael Brecht
Journal:  Science       Date:  2005-11-04       Impact factor: 47.728

Review 3.  Hippocampal long-term depression: master or minion in declarative memory processes?

Authors:  Anne Kemp; Denise Manahan-Vaughan
Journal:  Trends Neurosci       Date:  2007-01-17       Impact factor: 13.837

4.  Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD.

Authors:  Jing Han; Philip Kesner; Mathilde Metna-Laurent; Tingting Duan; Lin Xu; Francois Georges; Muriel Koehl; Djoher Nora Abrous; Juan Mendizabal-Zubiaga; Pedro Grandes; Qingsong Liu; Guang Bai; Wei Wang; Lize Xiong; Wei Ren; Giovanni Marsicano; Xia Zhang
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

5.  The group I mGlu receptor agonist DHPG induces a novel form of LTD in the CA1 region of the hippocampus.

Authors:  M J Palmer; A J Irving; G R Seabrook; D E Jane; G L Collingridge
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

6.  Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus.

Authors:  R Lujan; Z Nusser; J D Roberts; R Shigemoto; P Somogyi
Journal:  Eur J Neurosci       Date:  1996-07       Impact factor: 3.386

7.  The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission.

Authors:  Asami Tanimura; Maya Yamazaki; Yuki Hashimotodani; Motokazu Uchigashima; Shinya Kawata; Manabu Abe; Yoshihiro Kita; Kouichi Hashimoto; Takao Shimizu; Masahiko Watanabe; Kenji Sakimura; Masanobu Kano
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

8.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens.

Authors:  David Robbe; Manfred Kopf; Anne Remaury; Joel Bockaert; Olivier J Manzoni
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

Review 10.  LTP and LTD in cortical GABAergic interneurons: emerging rules and roles.

Authors:  Dimitri M Kullmann; Karri P Lamsa
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

View more
  36 in total

1.  LTD at mossy fiber synapses onto stratum lucidum interneurons requires TrkB and retrograde endocannabinoid signaling.

Authors:  Enhui Pan; Zirun Zhao; James O McNamara
Journal:  J Neurophysiol       Date:  2018-12-05       Impact factor: 2.714

Review 2.  The Corticohippocampal Circuit, Synaptic Plasticity, and Memory.

Authors:  Jayeeta Basu; Steven A Siegelbaum
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

3.  Cannabinoid-mediated short-term plasticity in hippocampus.

Authors:  Margarita Zachariou; Rüdiger Thul
Journal:  J Comput Neurosci       Date:  2014-08-16       Impact factor: 1.621

4.  Joint CP-AMPA and group I mGlu receptor activation is required for synaptic plasticity in dentate gyrus fast-spiking interneurons.

Authors:  Thomas Hainmueller; Kerstin Krieglstein; Akos Kulik; Marlene Bartos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-26       Impact factor: 11.205

5.  Direct excitation of parvalbumin-positive interneurons by M1 muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition.

Authors:  Feng Yi; Jackson Ball; Kurt E Stoll; Vaishali C Satpute; Samantha M Mitchell; Jordan L Pauli; Benjamin B Holloway; April D Johnston; Neil M Nathanson; Karl Deisseroth; David J Gerber; Susumu Tonegawa; J Josh Lawrence
Journal:  J Physiol       Date:  2014-05-30       Impact factor: 5.182

Review 6.  Synaptic functions of endocannabinoid signaling in health and disease.

Authors:  Alfonso Araque; Pablo E Castillo; Olivier J Manzoni; Raffaella Tonini
Journal:  Neuropharmacology       Date:  2017-06-15       Impact factor: 5.250

7.  Homer protein-metabotropic glutamate receptor binding regulates endocannabinoid signaling and affects hyperexcitability in a mouse model of fragile X syndrome.

Authors:  Ai-Hui Tang; Bradley E Alger
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 8.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 9.  Endogenous cannabinoid signaling at inhibitory interneurons.

Authors:  Thomas J Younts; Pablo E Castillo
Journal:  Curr Opin Neurobiol       Date:  2013-12-28       Impact factor: 6.627

10.  CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses.

Authors:  Thomas J Younts; Vivien Chevaleyre; Pablo E Castillo
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.